Proteasome Inhibitors: A New Perspective for Treating Autoimmune Diseases

E-ISSN： 1873-5592|13|13|1665-1675

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.13, 2012-12, pp. : 1665-1675

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A new target for proteasome inhibitors: FoxM1

By Gartel Andrei L

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 235-242

Informa Healthcare

Access to resources Recommend Favorite

Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 517-536

Bentham Science Publishers

Access to resources Recommend Favorite

New immunological approaches in treating and diagnosing CNS diseases

By Guo Kathy Janigro Damir

Pharmaceutical Patent Analyst, Vol. 2, Iss. 3, 2013-05 ,pp. : 361-371

Future Science

Access to resources Recommend Favorite

New Analytical Tools for Studying Autoimmune Diseases

Current Pharmaceutical Design, Vol. 12, Iss. 29, 2006-10 ,pp. : 3735-3742

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome Inhibitors: Recent Advances and New Perspectives In Medicinal Chemistry

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 3, 2010-02 ,pp. : 232-256

Bentham Science Publishers

Access to resources Recommend Favorite